Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You want to insult me when I offer the information I was provided. Listen, I enjoy contributing here to this board and hearing what others have to say. I offer my thoughts, which I provide based on rational logic and my experience. I have had a conversation with management, and provided all of the information in a factual way.
If you want to comment and suggested I am lying and call out my character, then I will refrain from posting here anymore.
I received word that development is progressing nicely. That small fluffy news releases are no longer going to be released. Major developments will be conveyed with time. The company has been preparing various media and materials for their next big news release, which will detail progress made on FAIMS, and plans moving forward. My interpretation was that management is letting the scientists do the work. Yost, Goldberger, and Boock. I have spoke with Goldberger, and I have spoke with Cannabix management. They all seem to believe that their device will, at the end of the day, be the best device - worldwide. They believe this because the FAIMS technology is superior. The key issue, is getting the ion mobility chamber into a miniature device. They will combine Alpha pieces that have been demonstrated as successful, through product iteration and testing thus far, with FAIMS technology. They will update their patents accordingly. It was not stated directly, but it is believed that the patent for FAIMS rights will be acquired before the deadline, meaning that these guys are going all in. They also mention that their costs are being minimized significantly to ensure they have the money for trial testing and continued development. They have the funds to do so at this time (directly stated by them). A news release, conveying these things, could happen anytime in the next few weeks, to a month. They mentioned it will likely be at the start of the new year. When I know their is a positive news release coming, I acquire more stock. So I have. Everyone does their on DD at the end of the day, I simply provide my thoughts here. I think the next news release will be a hit, because shareholders have always longed for some PROOF that device development is proceeding well. The next news release will offer just that.
Now to your second point. I apologize for the long post.
Thanks for the respectful comments. I do appreciate.
I try and bring rational scientifically backed thinking to this board, such that it provides benefit to those understanding the process we are going through.
At the end of the day, I was happy with my conversation with management. I have posted many times that I believe it is time for a update on progress, and am happy to hear we will be getting one quite soon.
I will continue to provide my thoughts to the board, so long as they are welcomed.
I have typically refrained from suggesting advice on stock moves. I try not to suggest people should buy or sell. I try and provide rational for management's moves, product development and timeline, etc. Only once have I suggested that our community members pick up stock, and I believe that time is now, simply because a news release is pending and though I do not know the specifics, the information I received, made me feel comfortable to add shares.
I was informed.
To suggest that Hound labs will be selling a product in a year is speculative. My belief is that will not happen. They haven't even announced that they have a device built that is 100% accurate. They dropped a little media tease. They mentioned they will be doing some testing. They are years, not a year, from having a device being used by police. In fact, it could be good if they have a device that moves the legal system forward toward considering breathalyzer detection by law enforcement. I think that competitors matter when it comes to sensitivity. The most accurate/sensitive device will win. Such is the nature of medical technology, where you are conducting a biochemical test in order to determine if someone requires legal punishment. You are talking about determining the fate of people's lives. There can be NO false positives, the sensitivity and specificity need to be near 100%. If Hound labs puts out a device that is not 100%, and Cannabix does, then who's breathalyzer gets purchased? Maybe Hound Labs is 100% accurate. No one knows. Mere speculation.
Euroconversions and GOLD DIGGAA, I make my claims based on the facts I have. The statement I made is informed and I have stuck to the facts. It is as analytic as possible... it is 1 sentence. A news release is on it's way, and most likely in the new year. I haven't fluffed it up with unknown facts.
I have spoken with management. I am quite happy with how things sounds. Much work has been done to improve promotional materials in such a way that shareholders will be informed of progress in due course. This will be conveyed in a news release and also in a new corporate package of promotional materials (including MEDIA, whatever that means... pics or videos).
I have posted here on my expectations of management, stating countless times that small scientific advancements are not meant to be conveyed to public. There is no point in that, as they can often confuse shareholders. This technology is VERY complex. I stand by my opinion that larger quarterly progress reports are a better way to keep shareholders in the loop. While I agree that there needs to be an update, the agreement with UFL was made in August. Scientific advancement does not happen overnight. This is not a penny-stock that will see an overnight rocket-ship ride to mars. I believe that SOON management needs to update shareholders as 3 months is about a good time to do so. Everyone on this board has speculated about Breathtec taking time away and such, with absolutely no proof that the work Mlait and Attariwala do with Yost, has been hindered in timeline. 3 months is not abnormal for a major update. With that said, a timeline was provided on Alpha, so I believe it is only fair that a timeline be provided on FAIMS.
I am pleased with the response I received from management. I will be increasing my investment over the next week or two. It is expected that news may come early new year. It doesn't matter to me if Hound Labs goes public, what matters to me is that Cannabix continues developing FAIMS, because I believe that to be the best technology for the job, scientifically speaking.
Most likely early new year. Big release coming.
You won't find anything relevant to Cannabix in there. It's a review article.
Thankfully we aren't relying on Mahli to run Cannabix and develop the science. If it wasn't for Yost I would be out. Yost is incredible and we are definitely lucky to have him involved.
I asked Golddiggga this question, and want to ask you the same - when we receive a wicked news update in the early new year, which features all of the updates that have been made with respect to FAIMS, what will you do?
I think that it has been about 3+ months, and it is time, but I would have to disagree management has let us down. They have personally contacted shareholders and returned emails to let them know that things are progressing well and that news and updated promotional material is coming.
I agree with the others that you need to stop thinking black and white. Having milestones like "beta prototype development" offer some sort of false hope that we have achieved our goal. That this penny stock will bounce around a bit as a result and you can cash out.
My opinion is that if you truly expected to see a stock price increase and product development so short term, it is you who has poorly invested in this company. This has never been a short term win. This is a complex bio-technology advance that has never been achieved before.
I invested before this dip, but I was, and am prepared for a long term development plan. At the end of the day, our next news release will let us know, HAS THE COMPANY BEEN WORKING DILIGENTLY. Simple, if they are making progress and have money, then we are set. They have the best technology out there, it's a matter of the steps to miniaturize it, regardless of other companies. Competition doesn't matter, if we eventually have a product that wins.
Can I ask a question: if come January, the company releases media showing the steps they have taken to build a product... and show some advances with their FAIMS... what will you do next?
I can tell you what I will do. Remain invested.
There won't be a "beta-prototype" in my opinion. FAIMS and Alpha need to get combined. It's actually quite a promising thought. As long as management has done there job in portraying us some faith. Yost doesn't update the public every 5 minutes.
What are you talking about... "Management has moved on".
Rav Mlait and the CFO Brian Loree have no affiliation with Cannabix. The CEO of Breathtec doesn't work with Cannabix, and Boock works with Cannabix and doesn't work with Breathtec. Attariwala got the device to the point it is at and worked on developing the initial patents. Those pieces won't go to waste. Yost oversees Boock and Costanzo and that is fine.
News will be released and people like yourself will realize that they have been working on their device.
My opinion is that you should not rely upon tabloids for your announcements and news pertaining to development of the technical marijuana breathalyzer. People continuously post to this page, taking unquoted material from newspapers and news outlets that have absolutely no credit. The company releases it's news updates through it's website. Management has stated that material has been developed and will be released soon for all to see how the company is progressing. The company has continued to advance it's technology. The Alpha device reach 80-90 percent sensitivity and the FAIMS technology is being pursued concurrently, but separately. The FAIMS technology and parts from Alpha will both contribute to a final product.
The main point to take home here, is that there is news coming. I fully expect the company to release something that provides shareholders with faith that Yost and Goldberger and Boock are progressing the technology. There is NO reason not to think that is the case. These world experts were commissioned a mere 3 months or so ago to work on this. Small tweaks to the design wouldn't be released in news announcements from management. Management will (as they have said they will) provide an announcement soon.
With regards to the option on the patent, they will acquire that option. If they do not, the company will dissolve, as this company needs the FAIMS. As such, expect a news article in the next month or so, and expect the patent to be acquired by the summer. Simple.
Things are moving well in my opinion.
Not in quotes.
I don't think jumping to such assumptions based on a small new outlet publishing unquoted material is a good idea.
Yost has said before (and published) work showing that they are beyond that point in development and have detected THC in breath.
Cannabix has stated they have >80% accuracy.
Agreed. I still believe that it be a poor investment choice to put money into Breathtec, when management has yet to follow through on Cannabix. 1.5 years and no public demonstration of a working device. If I see a working FAIMS, I will be investing in Breathtec... in due time. Too much uncertainty atm.
Breathtec IPO launch clearly got held up for whatever reason.
Interesting. Shouldn't see anything surprising in it... company still generates no income and we have yet to hear any news... and no insider sells to the public. Yawn.
From the Interim Financial Statement:
"Management is of the opinion that sufficient working capital will be obtained from external financing to meet the Company’s liabilities
and commitments as they become due..."
One thing we know for sure... speaking from experience. There won't be a full patent filed on the Alpha technology. That would be a huge (anywhere from 80k-250k) waste of money if they are only achieving 80% accuracy and they expect the FAIMS device to be "100%" accurate.
If we see a full patent, it will be the holy grail and sign that we have hit the jackpot.
One thing I should mention. Now seems like a great time to pick up some shares, pending the upcoming news (which management has stated is coming, to one of the fam here).
I think it is safe to say their is nothing of significance from a business perspective. We wouldn't get an update through the monthly report, on the scientific advance/product development specifics in that report anyway. As it has been posted on this board recently, we can expect some significant updates soon from management as to timelines and recent product development successes... given that management responded by email to one of our family.
Hopefully this week we will get some uplifting news. I think we are still in the dark atm. Fingers crossed.
*optimized... could suggest they already have it in hand-held form but needs to be better... OR... could mean they don't, as you have eluded to. Tough to say. Regardless, some uneducated investors were throwing stock away yesterday based on speculation and fear. Expected though I guess.
There's nothing wrong with competition, because Yost is the one to be invested in... his experience trumps all.
Holy f*ck does anyone see anything wrong with this article:
http://www.financialstrend.com/it-is-a-relieve-for-drivers-who-want-to-drive-and-smoke-marijuana-23920.html
*Ingnstrng - my guess on the development of FAIMS, is about the same amount of time that the Breathtec device will take for it's development proposed in their prospectus recently. About 1 year for development and trial initiation.
I don't think Hound Labs will be any quicker.
I think the most important thing for all investors to realize is that, Cannabix has been quiet, they don't need to announce every small advance. Yost has probably suggested they don't. The new UFL agreement puts a damper on the ability to release tons of news, and who wants to give away all the secrets. At the end of the day, investors should care about the following ... is management making advances to develop the FAIMS device, because, the FAIMS device is the technology with the most potential in the world in terms of accuracy. We also have the most talented advisor for the job in Yost. Simple. Cannabix, HAS IMHO made timely advances and when Alpha didn't work, they pulled through for shareholders in announcing the UFL partnership. I don't see any issue so far. While some will say management has let shareholders down, I would disagree. They worked on Breathtec, so what, if they have Yost working on the Cannabix device and *hired Boock*, then they have time to work on Breathtec because they are businessmen, and Yost and Boock are working hard on a device, and that work just began, so of course there won't be an announcememt ready. Even if all the investors on this forum teamed up, they wouldn't be able to develop a Yost quality device. Even if all the investors on this form worked together for 40 years, it wouldn't happen. Yost is a special, genius, world renowned chemist.
Have faith!
What did you hear from management. And when?
I disagree in that I believe our first device will be FAIMS. Cannabix will not waste their time producing a device that is a simple yes/no... they could have done that a long time ago.
Your need to understand that FAIMS WILL detect THC in breath in 1-2 blows... it's the current Alpha that cannot. They use separate technology. Nothing to worry about there. When FAIMS is released, it will be superior to all other breathalyzers, for the many reasons we have discussed before.
You need to also stop relying on the thought that we might be able to "catch people" with a violation of a patent. Our patent application is not even CLOSE to being detailed enough to cause a violation from Lynn's work. Your comment on the analysis method means nothing... it is a subclaim to claim 1. Patents don't work so simply. All those guys have to do is provide more detail and be specific with measurements and time periods and they bust the patent in two seconds. They also have a top notch patent lawyer working for them...
You need to put your faith into the development of FAIMS, let us be real here.
"maybe BreathTec will want some BLOZF/BLO shares".
That would be the day.
So you are suggesting that they are purposefully watching the price drop on shareholders, and that they would have loved to cash in on a run when the FAIMS deal was first announced, but didn't get it, so they are watching the price tank before they announce again...?
But Yost has demonstrated his success.
What happened today? Someone want to explain, I was tied up.
So this confirms my point about it "running dry", i.e. requiring multiple cartridges.
Still, none of that is in quotes.
Definitely a lot of speculation. We know hardly anything about this company. Seems to me like a lot of panic today because of some competition. I don't see the big deal. If Cannabix develops a wicked accurate FAIMS, then we will come out on top. Holding sucks in the face of such speculation is tough, but as a smart investor, this is the tough time where faith matter and it's got to be done. We invested in the technology ... the FAIMS... not the timeline and the media hype.
Hound Labs device will not collect DNA. The Tag molecule will essentially "grab" the THC out of the breath. No DNA at all.
Looks to me like trading has been held on the Canadian side since 9:30am Eastern? And on the American side since 12:24.
News time?
At the end of the day, it doesn't matter.
The original patent would have been setting the stage for a full patent covering a device using the swedish technology. That device doesn't look like it played out (see Sept. 16th news release).
A new patent will be filed on FAIMS. Depending on how things work, it could end up being an extension of the original patent though... as it still involves THC detection by breath.
You are speculating though... no evidence and without experience in patent literature, you are beating a moot point to death. Who cares.
At the end of the day, even if Hound Labs makes a device, if we make a better one a few months later, than people buy ours. This is not a one device game like people have made it out to be...
Not to mention, nobody will have anything for sale for years... SOOOOO much work to be done before then with testing and legalization.
I would say no. It wouldn't need "recharging" or "recalibration". There would nothing wrong with the device and electrically there would be no isssue. Rather, the device would "run dry" and need more chemical. Imagine they could sell "back-up cartridges that could replenish the tag molecule in the device. It would likely be expensive... if the "tag molecule" is an expensive chemical, or hard to produce. If the "tag molecule" is a cheap and widely available chemical, then they could sell these replenishing cartridges for cheap.
This is my guess. But I should also note, that they may only need super small quantities of this chemical for each detection, and thus technically could be good for thousands of breaths. It is hard to say.
Another factor to consider would be the lifespan of the chemical. Not all chemicals stay preserved in their original form forever. That's the biggest issue I see with their device. If the chemical starts to deteriorate, then basically the device is less sensitive. So if a police department has these things in a moisture environment in the back of a squad car every day and the chemical degrades over a year span, then all the sudden people who are blowing into the device are not getting detected because the tag molecule has gone to shit. They need lengthy clinical trials in all kinds of environments to know this stuff. A lot of the chemical qualities will already be known though, as "time to degradation" is a characteristic unique to the chemical and perhaps this is a really stable chemical to oxygen and moisture. It needs to be air stable, because... it is interacting with breath.
Agreed Majorkaos: no evidence to his claims.
Our provisional patent that was released was not meant to cover a FAIMS device. It has been intended from day 1 that a new patent would be filed. I cannot comment specifically, but, I do believe that the patent that we have now, does cover THC detection by breath, so there could be infringement.
Your other comments, no offense, have absolutely no backing and are uninformed.
The pairing with an alcohol breathalyzer is a trivial point in the grand scheme of things, as law enforcement wants the most accurate device. The accuracy is the determining factor of who wins this race,
Their concept is not "better". It is different. I JUST explained that. Our device would likely be better if it is achievable.
How do you know it will be "cheaper"... please feel free to try and explain how you have any clue that their complex detection system would be cheaper than our complex detection system.
You need to chill! You are making claims based on NO evidence.
My science Input:
Your first question: Their device will likely be battery powered. What I am eluding to is that Hound Labs device will not be rechargeable in the chemical sense. Battery rechargeable yes... chemicals, likely not. I am suggesting that the device will have a set amount of "tag" chemical within. It might be good for detecting 1000 blows (just an example). Every time someone blows, a bit of the "tag" molecule is released and allowed to interact with any THC in the breath that it comes into contact with. So in that sense, the chemical detection method has a limited life span. If Cannabix can release a THC detection device using FAIMS, it will not have a limited chemical lifespan, because it is not using a chemical detection method (well... not entirely) as it relies upon separation of the molecules in breath based on the charge and size of ions that get through the port and into the "separation chamber". The time of flight of the molecule in the electrode will correspond to the size and charge. Each molecule thus has it's own "electronic finger print". Hence why some like Shell3, refer to "DNA". It is not actually DNA, but the electronic reading is composed of signals. Each signal on the reading corresponds to a certain molecule of size and charge like I mentioned. THC-9 will have a specific charge and size and so it will be a stand alone peak. I know they can get a single peak, based on the sensitivity they claim. As such, the device is programmed to look for a peak at the part of the electronic reading where THC SHOULD BE if it is present. If someone smoked in 2 hours, their will be a peak there, and the device will go off.
To address your second question. To make the chemical device, they do not necessarily need a fancy, high tech electronic device like FAIMS, it is probably more simplified. They are working on chemically detecting molecules. Here is my proposition. The two chemists that work on the Hound Labs team have training in the engineering of equipment for detection purposes, i.e. Dan Fletcher, who is the specialist who would contribute to the instrumentation construction as he is a specialist in "Imaging & Biomedical Instrumentation"
From his website:
"Optical microscopy, force microscopy, microfabrication, and microfluidics provide the opportunity to monitor and manipulate biological assembly. When existing approaches don’t allow us to measure what we need to measure, we develop new methods. Our work on optical microscopy has led to low-cost diagnostic technologies for global health (CellScope) and an introductory optics instructional kit."
The other scientist Matt Francis would contribute the following: "New Methods for Site-Selective Protein Modification"
From his website:
A central theme in this research program is the modification of structural proteins in specific locations in order to achieve homogeneous and predictable assembly. Site-directed mutagenesis provides a powerful set of tools for this purpose, and will be used extensively. However, there are limitations associated with this technique, and therefore the development of new chemical approaches for protein modification will be pursued as well. This research will take advantage of the rapidly expanding set of organic reactions that can proceed in aqueous solution, and will utilize asymmetric ligands and catalysts to enhance the selectivity of protein modifications. Combinatorial reaction libraries will play an important role in this research area.
So basically, my understanding is that Matt Francis would identify a ligand (i.e. the tag molecule) and that would be able to bind to THC in breath as the tag molecule can mix with the breath sample. The molecule is now of a much higher molecular weight and as such, given it is much bigger (and concentration is size/volume when you account for molecular weight)... you have a basically super sized THC molecule with a tag on it, so you don't need to "look as hard", i.e. don't need as sensitive a detection method, i.e. don't need to blow into the device 20 times to get the concentration of THC up. Now, bring in Dan Fletcher. He builds the device that could use a high tech imaging to see the THC-tag molecule. My guess is that when the tag binds to the THC, it gives off a certain wave length of light, and thus has a unique "signature" and the device that Dan Fletcher has built, will capture that light at that wavelength and thus, you can detect THC.
Hope that makes sense. It is my opinion, given experience in this field.
Your third question:
I would say they have the technique and device built. So their timeline of 1 year seems reasonable. Especially since they claim they are starting trial testing in Q1 of 2016. That is the bad news.
Fourth question:
FAIMS as I mentioned above, is different than this tag-Thc molecule detection system. FAIMS doesn't require some "add-in" chemical that binds to THC, FAIMS finds THC itself. FAIMS measures ions as they separate in an electrode and thus uses electricity (current) to generate the signal, and the signal is specific to the size and charge of molecule. THC-Tag is a chemical way of making THC bigger and thus increasing the concentration of the molecule you are searching for in solution, and as I mentioned, it will likely have a certain light/wavelength/detection property that is unique and they can get a reading on.
It is funny how speculation leads people to panic and dump shares. I will probably pick up some more at a good price if so. The race is real - no insider sales in the public = Cannabix isn't phased, they are still in it to win it.
Imagine if we get Beta release this week.
Cannabix PowerPoint is being updated... that will tell all.
Hound Labs is genius, they found a tag molecule to "attach" to the THC, and thus they can detect it at levels that are super dilute, rather than going on searching for THC itself in very small quantities. Brilliant.
I should point something out now though. If they require a "chemical reaction" where THC in breath runs through the device port and reacts with a "tag molecule", this suggests that there could only be a limited life span to their device, because there can only be so much chemical in the device. I.e. it would not be "rechargeable" with some new batteries. There device may be expensive and replacing it frequently might not be something police want to do all the time for $1000 a pop. Cannabix might only need some new batteries and voila.
Keep our heads up here. No need to panic yet. Soon. Just not yet.
Without a doubt it is going to be a close race.
I stand by the fact that nobody should be investing in Breathtec before knowing if Cannabix can follow through. But that is my belief. It is not a safe play at this time. The CEO is a fresh graduate with NO experience. He is working with Cannabix's management, who have not pulled through for Cannabix shareholders yet. I don't see how that could be a good choice at this time.
I also believe that Yost has the capability to do what Hound Labs does, and potentially better, given his experience... WAY more experience in this field compared to the others.
Until someone shows results from trial testing, I think this is a hold.
Cannabix should provide an update that provides a timeline for development.
e"In just one or two breaths, our new scientific approach is able to capture THC, and, through an extraction process, measure the actual level to less than 500 picograms," said UC Berkeley professor and Associate Dean of the College of Chemistry, Matt Francis. "This incredibly efficient and responsive technology is necessary to measure THC which requires a method that is more than one million times more sensitive than what is used to measure alcohol in breath."
If they have a technology that can detect down to 500 picograms, I can guarantee that they will successfully demonstrate through clinical trial that they can accurately quantify THC in breath, as this is far below the detection limit (nanograms) that would legally be required.
Look at the two scientists, Matt Francis and Dan Fletcher at Berkeley (the top ranked chemistry department in the world). They are both well-published for the age and have incredible training backgrounds.
I would not take this lightly.
Note: the device can detect alcohol and THC. I recommend going to the two scientists websites and looking at some of their publications. They have the tools to make it happen.
I will post my thoughts on what their science might entail, soon.
For now, lets hope Cannabix puts out some news...
Second point:
I would highly advise against investing in Breathtec Biomedical, as this management team has failed to inform investors with timely updates on technology development, lacking transparency. Even if they have been busy with the other company, IMHO they have let shareholders down.
Why invest in a new company when they couldn't even follow through on the first? They have yet to demonstrate a working device to the public. I personally WILL invest in Breathtec after I see a working THC detection breathalyzer, but until that, they do not have my confidence, and thus, will not be getting a dollar.
Whoever recently posted about science and engineering makes a good point. You can talk about having the science, but at the end of the day, if you do not have the device and the team to market it, then your company will lose it's share value (e.g. Cannabix).
They technically have a (self-reported...) very accurate device that is the equivalent to their "beta".
So they are ahead of the game, but again, this is self-reported.
The trial will be "public" in that a third-party will conduct it, likely. They have done their own testing to prove it's accuracy, but that isn't good enough for court proof. A trial must be started, and it will take plenty of time. Then legal validation.
We still have time, but Cannabix better get it's stuff together.